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INTRODUCTION
The prevalence of adult obesity is increasing dramatically 
worldwide (1). Many disorders accompany obesity, including 
sleep apnea, gall bladder disease, cardiovascular disease, 
dyslipidemia, hyperinsulinemia, type 2 diabetes mellitus, 
and nonalcoholic fatty liver disease (NAFLD). NAFLD is 
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increasingly recognized as a potential complication of 
obesity (2-9). NAFLD ranges from simple steatosis, through 
fibrosis, to cryptogenic cirrhosis. NAFLD is the most 
common cause of elevated liver enzyme concentrations and 
is currently the third leading cause of liver cirrhosis (2-9). 
A liver biopsy is the gold standard for the determination 
of hepatic fat morphology and severity. Since biopsy is 
an invasive procedure, its use is limited. Non-invasive 
techniques, such as magnetic resonance imaging (MRI), 
have also been used to examine total or regional body 
fat (intra-abdominal or subcutaneous fat) and hepatic fat 
content (2-10).  
Intra-abdominal adipose tissues can be sub-divided into 
intraperitoneal and retroperitoneal adipose tissues. Such 
regional adiposity is believed to be important because 
venous drainage of the intraperitoneal adipose tissue goes 
directly to the liver, through the portal vein, whereas the 
retroperitoneal adipose tissue drains into the systemic 
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Radiologic Examination
All patient and control subject sonographic examinations 
were performed using the Antares Ultrasound System 
(Siemens Inc., Mountain View, CA), equipped with 
a multifrequency (2-5 MHz) convex transducer. All 
patients with nonalcoholic steatohepatitis underwent 
a “hyperechogenic liver with B-mode” US examination, 
whereas the control subjects underwent a normal liver 
parenchyma US examination. Both the patients and control 
subjects fasted overnight before US. All eight segments of 
the liver were carefully scanned, and subjects with vascular 
malformations or hepatic masses (e.g., cyst or hemangioma) 
were excluded. Doppler US of the portal vein showed a 
wide spectrum of different flow patterns and velocity in 
healthy patients. An important limitation of Doppler US is 
reproducibility or accurate measurements. To compensate 
for this limitation, we standardized each measurement. 
For each duplex scanning, the sample gate was adjusted 
between 6-10 mm (depending on the diameter of the 
vessel). Moreover, the portal vein spectral analyses were 
always recorded for at least 2-3 cycles. The transducer was 
oriented along the longitudinal axis of the main portal vein 
using a paramedian or slightly oblique plan. The point of 
measurement was midway between the confluence of the 
splenic and superior mesenteric veins and the bifurcation 
of the portal vein during quiet inspiration by the same 
sonographer. The Doppler angle was always < 60º. The 
maximum (Vmax) and minimum (Vmin) velocities (cm/s) were 
recorded in each patient and healthy subject and were 
photodocumented (Fig. 1). The difference between Vmax 
and Vmin was calculated as a parameter of biphasic (slightly 
pulsatile) or monophasic oscillation.
All MRI studies were performed with the 1.5 Tesla clinical 
MR imaging system (Magnetom; Siemens Medical Systems, 
Erlangen, Germany) and a phased array body coil. All MRI 
examinations were performed with the following protocol: 
transverse dual fast in and out and phase T1-weighted 
gradient echo sequences of the upper abdomen, from the 
diaphragm to the umbilical level (repetition time [ms]/
echo time [ms], 100/2.38-4.97; flip angle, 70º; 30 sections 
acquired in a 44/3 second multi-breath hold). Section 
thicknesses were 7 mm and the matrix size was 145 × 256 
(phase frequency encoding).
Image post-processing was performed using a workstation 
(Volume Wizard; Siemens Medical Systems). For each 
image pair (one in-phase and one out-of-phase image at 
corresponding levels), a region of interest (ROI) was drawn 
circulation. Thus, free fatty acids, glycerol, and other 
adipocytokines that are released from the intraperitoneal 
adipose tissue may influence the hepatic metabolism of 
glucose, triglycerides, insulin, and other substrates and 
hormones. The portal fat hypothesis is based on this unique 
pattern of venous drainage (2-10).  
In the present study, we examined the relationship 
between portal venous velocity and hepatic-abdominal 
steatosis. The confirmation of a relationship between 
these entities would suggest that alternative non-invasive 
modalities, such as duplex US and MRI examinations, could 
be used for the management of patients with NAFLD. A 
second aim was to determine the relationship between 
the hepatic fat fraction and abdominal-subcutaneous lipid 
accumulation in patients with NAFLD.
MATERIALS AND METHODS
Subjects 
Between August 2006 and May 2007, 35 patients with 
NAFLD attending our gastroenterology outpatient clinic 
were enrolled (M:F = 23:12; mean age, 46 ± 10 years; 
range, 26-70 years). The diagnosis of NAFLD was based on 
abnormal levels of serum aminotransferases. Body mass 
index (BMI) was calculated in each subject. Patients with 
a BMI between 25 and < 30 were regarded overweight and 
a BMI > 30 were regarded as obese. Fifteen patients had 
type 2 diabetes mellitus. Malignant and infectious diseases 
(viral hepatitis) were excluded by appropriate clinical, 
laboratory, and imaging investigations. Heart disease was 
excluded based on medical history, physical findings, chest 
radiograph, electrocardiography, and echocardiography. In 
all 35 patients, appropriate visualization of the liver vessels 
was achieved by transabdominal B-mode sonography, and 
adequate Doppler sonography was obtained by duplex 
scanning.
The control group was made of 29 normal healthy adults 
(M:F = 14:15; mean age, 42 ± 8 years; range, 23-65 years) 
and examined by B-mode and duplex Doppler sonography. 
All healthy subjects had liver function test results within 
normal ranges. Chronic liver (infectious, metabolic, toxic 
auto-immune) diseases and heart diseases were ruled out 
by appropriate testing. 
The present study (project number: KA06/236) was 
approved by our Institutional Ethics Committee. Each 
patient provided written informed consent to participate in 
this study.Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 452
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in the liver in five different segments (segments 8, 7, 4, 6, 
and 1), using an adjustable, round cursor. The ROI selected 
in each image was at least 2.0-2.5 cm
2 and was located in 
the liver parenchyma to exclude contamination from blood 
vessels, motion artifacts, or partial volume effects. The 
mean pixel signal intensity (SI) values for each ROI and 
for each of five liver segments were recorded. Hepatic fat 
fractions were calculated using a modified Dixon method 
(MR chemical shift imaging) from the mean pixel signal 
intensity data, using the formula: fat fraction = SIin-phase - 
(SIout-of phase/2 SIin-phase) (11-14).  
For each patient, five separate fat fractions were 
obtained, one in each of the five image slice pairs (Fig. 
2). The calculated fat fractions were then averaged to 
determine the mean fat fraction. The hepatic fat fraction 
was considered to be normal when a value was below 9% 
(11-14).  
Measurements of adipose tissue (subcutaneous, intra-
retroperitoneal) were performed manually using a 
workstation (Volume Wizard). In all patients with NAFLD, 
adipose tissue was measured in a single image at the level 
of the umbilicus, as these values have been found to be 
A B
Fig. 1. Spectral Doppler US of maximum velocities in portal veins of control subjects and patients with nonalcoholic steatohepatitis 
(NAFLD). 
A. Maximum velocity (Vmax) in portal vein of normal subject (43.30 cm/s). B. Vmax in portal vein of patient with NAFLD (18.10 cm/s).
A B
Fig. 2. In-phase (A) and out-of-phase (B) images, with corresponding signal intensities, are shown for individual with steatosis (32%). 
Circle in each image represents region of interest. Region of interest signal intensities are from same slice. In-phase and out-of-phase images 
were used to derive hepatic fat fraction, according to equation: fat fraction = SIin-phase - (SIout-of phase / 2 SIin-phase).Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 453
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excellent surrogate measures of whole-abdomen values (15, 
16).  
On T1-weighted MR images, adipose tissues are clearly 
demarcated as bright areas, with signal intensities that are 
higher than those of other tissues. Intra-abdominal adipose 
tissues were separated into intra- and retro-peritoneal 
adipose tissue compartments using anatomical points such 
as the ascending-descending colon, aorta, and inferior vena 
cava. This was achieved by visual mapping of the anatomic 
area of a single slice at the level of the umbilicus on the 
computer screen using a mouse pointer (Fig. 3). The pixels 
in each anatomic area were counted and converted into a 
volume by multiplying the number of pixels by the voxel 
size (voxel size, 2.4 × 1.6 × 7.0 mm = 26.88 mm
3). The 
adipose tissue mass in each compartment was calculated.
Statistical Analyses 
Statistical analyses were conducted using the Statistical 
Package for the Social Sciences version 11.0 (SPSS Inc., 
Chicago, IL). A Pearson’s correlation was used to test 
whether there was an association between hepatic fat 
fraction with intra-abdominal and subcutaneous adipose 
tissue. The Student’s t test was used to compare differences 
in portal vein velocity between healthy control subjects and 
patients with NAFLD. Differences exhibiting a p value less 
than 0.05 were deemed to be statistically significant.
RESULTS
All patients with NAFLD were obese, which was defined as 
a body mass index (BMI) > 30.
The hepatic fat fraction in all patients with NAFLD was > 
9% (range, 9-46%). The portal vein waveform was biphasic 
(slightly pulsatile) in all healthy subjects and patients with 
NAFLD. The difference in portal venous velocity between 
patients with NAFLD and the controls was significant (p < 
0.0001). A flat waveform was not seen in any patient with 
NAFLD. The mean portal vein velocity in the controls was 
32.15 cm/s (range, 13.60-55.00 cm/s), compared to 27.60 
cm/s (range, 18.10-46.60 cm/s) in patients with NAFLD. 
There was no correlation between the degree of hepatic 
fat fraction and portal venous velocity (p > 0.05, R: 0.27). 
Similarly, there was no correlation between portal venous 
velocity and subcutaneous or abdominal adiposity (p > 
0.05, R: 0.34). However, there was a strong correlation 
between the degree of subcutaneous adiposity and the 
hepatic fat fraction (p < 0.0001, R: 0.84). There was also 
a strong correlation between the hepatic fat fraction and 
intraperitoneal fat accumulation (p = 0.017, R: 0.63). 
Similarly, there was a strong correlation between the 
hepatic fat fraction and retroperitoneal fat accumulation (p 
< 0.0001, R: 0.73).
DISCUSSION
The normal flow pattern in the portal vein is biphasic 
with undulation (17). Dietrich and colleagues (17) 
observed a decrease in undulation for the portal vein flow 
pattern in 135 patients with chronic hepatitis C who had 
undergone liver biopsies. The pattern was associated with 
portal inflammation but not with other parameters of the 
histologic activity index or intrahepatic fat deposition. 
They reported that this flattening was due to both a 
reduction in the maximum velocity and an increase in the 
minimum velocity. Icer and Kara (18) studied 17 patients 
with cirrhosis and 20 healthy subjects; the portal vein 
Doppler spectral waveform was changed in patients with 
cirrhosis compared with the healthy subjects. Healthy 
subjects had a more pulsatile pattern and broader spectrum 
than cirrhosis patients. Barakat et al. (19) studied 148 
patients with cirrhosis and 54 healthy subjects and showed 
that a flat, non-pulsatile pattern tended to increase in 
relation to the portal vein as the liver disease progressed. 
All these previous studies (17-19) demonstrated that portal 
vein Doppler spectral waveform alterations are dependent 
upon liver texture, with changes seen in association 
with, for example, cirrhosis, viral hepatitis, and portal 
inflammation. However, we excluded such patients, since 
Fig. 3. Axial T1-weighted MR image at umbilical level, with 
outlined subcutaneous adipose tissue and intra-abdominal adipose 
tissue (intra- and retro-peritoneal) compartments. Subcutaneous 
adipose tissue; section 1, retroperitoneal adipose tissue; sections 2 
and 3, intraperitoneal adipose tissue; section 4.Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 454
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these diseases are more harmful than NAFLD and damage 
the liver texture. In contrast to the above-mentioned 
findings, we did not see a flat waveform in any patient with 
NAFLD.
Balci et al. (20) studied 105 patients with hepatosteatosis 
and 35 healthy subjects. Their patient group was 
homogenous with diffuse fatty infiltration. They concluded 
that the pulsatility index and mean velocity of the portal 
vein blood flow decreased as the severity of fatty infiltration 
increased. However, we found no correlation between the 
degree of hepatic fat fraction and portal venous velocity (p 
> 0.05). Similarly, we found that the difference in portal 
venous velocity between the patients with NAFLD and the 
control group was statistically significant (p < 0.0001). 
However, the fatty infiltration score was determined solely 
on the basis of gray-scale images of the liver parenchyma, 
where other (more reliable) radiologic methods existed. 
The examination of portal venous velocities using US in 
patients with NAFLD indicate that the portal vein pulse 
Doppler values may be useful for disease diagnosis and the 
monitoring of responses to treatment. As a methodology, 
it involves no radiation exposure, is readily available, 
and is inexpensive. Determination of the Doppler spectral 
waveform in patients with NAFLD, who are diagnosed based 
on abnormal levels of serum aminotransferases, prolongs the 
duration of a typical US examination by only 1-2 minutes.
Various epidemiologic studies have noted associations 
between increased waist-to-hip-circumference ratio and 
impaired glucose tolerance, type 2 diabetes mellitus, 
hypertriglyceridemia, hypercholesterolemia, hyperuricemia, 
(13-16) and atherosclerotic vascular diseases (21-23). 
Bjorntorp (6) stated that fat in the intraperitoneal region 
may be more harmful and may influence insulin sensitivity. 
In another study, Jensen and Johnson (5) reported that 
intraperitoneal adipose tissue contributed to only about 
15% of the total systemic free fatty acid (FFA) inflow; the 
majority of FFAs (75%) came from non-splanchnic adipose 
tissues in the upper body such as the head, neck, trunk, 
and upper extremities. Likewise, we found that there 
was a strong correlation between the hepatic fat fraction 
and the levels of subcutaneous adiposity as well as the 
intraperitoneal and retroperitoneal fat accumulation. 
According to our findings, regional adiposity, for example, 
intraperitoneal adipose tissue, does not influence 
the hepatic fat fraction more than other regional fat 
accumulation. 
In summary, the main portal vein velocities in patients 
with NAFLD were lower than those in healthy subjects. 
However, the portal vein flow pattern was not changed by 
the degree of hepatic fat accumulation in patients with 
NAFLD. In summary, abdominal obesity is an important 
disorder that can influence hepatic fat accumulation; hence, 
it is important to find less invasive techniques such as 
described in this study to detect NAFLD.
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